Catalyst Pharmaceuticals Inc (CPRX)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 491,734 | 398,204 | 214,203 | 140,833 | 119,073 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $491,734K ÷ $—K
= —
The data provided shows that Catalyst Pharmaceuticals Inc's receivables turnover for the years from 2020 to 2024 is not available ("\u2014"). Without specific numerical values for receivables turnover, it is difficult to assess the company's efficiency in collecting receivables from its customers during these periods. Receivables turnover is a key financial ratio that indicates how many times a company converts its accounts receivable into cash within a given period.
In order to conduct a thorough analysis of Catalyst Pharmaceuticals Inc's receivables turnover, it is essential to have the precise figures for this ratio across the years in question. Having this information would allow for a deeper understanding of the company's effectiveness in managing its accounts receivable and collecting payments in a timely manner.
Peer comparison
Dec 31, 2024